\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
ProgrammesThe EUDIS Business Accelerator has opened applications for its third cohort, with a deadline of 30 May 2026. The eight-month programme is designed to start in September 2026 and support 20 start-ups and scale-ups developing defence or dual-use technologies. It is open to companies based in EU Member States or Norway.
After earlier cohorts launched in June 2025 and March 2026, the EUDIS Business Accelerator is now opening its third edition. The programme is designed to run for eight months from September 2026 and aims to help 20 high-potential start-ups and scale-ups strengthen their position in the European defence innovation ecosystem.
Selected participants are expected to receive tailored coaching and training from dedicated coaches and defence-sector experts, take part in five in-person bootcamps across Europe, and gain networking opportunities with industry leaders, end users and investors.
The programme also includes a seed funding voucher of €120,000 based on progress during the accelerator, as well as an additional reward voucher for the strongest-performing participants.
The call is open to start-ups and scale-ups established in EU Member States or Norway that are developing defence or dual-use technologies. An online information webinar is scheduled for 29 April 2026.
Interested companies can review the programme details and application process at https://eudis-business-accelerator.eu/.
They can also register for the information webinar on 29 April 2026 at https://eudis-business-accelerator.eu/informative-webinar/ before preparing an application by 30 May 2026.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Civil Security Digital, Industry & Space Agro-Food, Environment
The European Innovation Council has launched a call to recruit independent experts of diverse innovative defence and dual-use technologies (as eg. maritime, medical, drones, financial expertise, ..). It is important for the EIC to have a solid batch of experts with a balanced national diversity. Note that, as a requirement and due to security sens... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
